Stockreport

Acadia Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF - Company expects to receive a negative opinion following oral explanation feedback and intends to request re-examination upon review of formal adoption. SAN DIEGO--( [Read more]